Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$467K Buy
+21,326
New +$574K ﹤0.01% 5642

Other funds holding APMD

Morgan Stanley's APMD Position: Q3 2026 in Review

Morgan Stanley opened a new position in Apnimed (APMD) in Q3 2026: 21,326 shares worth $467K. The stake represents ﹤0.01% of the portfolio and ranks #5642 among its holdings.

71 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • Morgan Stanley held 21,326 shares of Apnimed worth $467K as of Q3 2026.
  • Apnimed was a new Morgan Stanley position in Q3 2026.
  • Apnimed made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5642 holding.
  • 71 funds tracked by Wall St. Rank held Apnimed as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.